iCarbonX IntelliCore has developed an in vitro diagnostic product portfolio based on silicon-based peptide chips and PNA chips, covering oncology, autoimmune diseases, allergies, and pathogen detection. The silicon-based chip platform offers high sensitivity, broad-spectrum target coverage, low sample-volume requirements, high specificity, and a low average cost per target, enabling the parallel analysis of multiple targets within a single testing system.

IVD Reagents and Supporting Equipment Portfolio

Oncology Testing Products

• Pan-Cancer Somatic Mutation Detection Kit (Chip Fluorescence Method): Covers 29,121 tumor somatic mutation sites, 1,218 lymphoma-related mutation sites, and 9,831 hereditary cancer risk-associated sites. Intended applications include companion diagnostics, prognosis and recurrence assessment, and therapeutic response evaluation.
• Pan-Cancer Methylation Biomarker Detection Kit (Chip Fluorescence Method): Covers methylation sites associated with multiple cancer types and is intended for early screening, diagnosis, and tissue-of-origin tracing.
• Pan-Cancer Protein Biomarker Detection Kit (Chip Fluorescence Method): Covers tumor-associated proteins including CEA, CA19-9, CYFRA21-1, and CA50, supporting auxiliary diagnosis, disease monitoring, and therapeutic response assessment.

Autoimmune, Allergy, and Pathogen Detection Products

The product portfolio also includes the Anti-Smith Ribonucleoprotein Antibody Detection Kit, Allergen-Specific Antibody Profile Detection Kit, Chronic Immune Intolerance Antibody Profile Detection Kit, Pathogen Antibody Profile Detection Kit, and Pathogen Antibody and Nucleic Acid Detection Kit. These products cover autoimmune-related antibodies, allergen species and proteins, antibodies against common pathogens, and pathogen nucleic acid detection.